Loading…
Hosted by Unknown Host · 🇺🇸 US · EN · 81 episodes
Established thought leaders with verified media credentials.
The ECTRIMS Podcast is a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.
Unknown Host hosts The ECTRIMS Podcast, a science show with 81 episodes published.
Technology is opening new possibilities for how multiple sclerosis is monitored, treated and managed. In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Ellen Mowry of Johns Hopkins University
Could multiple sclerosis one day be detected before symptoms appear? And if so, should we be actively screening people who are at higher risk? In this episode of the ECTRIMS–MS Journal collaboration series, host Prof. An
Where someone lives can profoundly influence their multiple sclerosis journey. While advances in diagnosis and treatment have transformed MS care in many parts of the world, millions of people still face significant barr
Welcome to MS Research Briefs, a new ECTRIMS podcast series delivering an expert guided tour of important new studies in multiple sclerosis research. In each episode, leading MS experts will take a small number of recent
Vitamin D and multiple sclerosis have been linked for decades, but how strong is the evidence – and what does it mean for clinical practice? In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. E
In this episode of the ECTRIMS Podcast, recorded in collaboration with the Multiple Sclerosis Journal "Controversies in MS" series, host Prof. Anneke van der Walt moderates a discussion between Prof. Andy Solomon and Pro
Epstein–Barr virus (EBV) has become one of the most intensely studied topics in multiple sclerosis research. But how strong is the evidence linking EBV to MS, and could targeting the virus change the future of treatment
New Phase 3 data presented at the AAN conference 2026 provide compelling evidence that fenebrutinib may represent a high-efficacy oral treatment option for people living with relapsing multiple sclerosis. In this exclusi
Imaging techniques in multiple sclerosis are evolving rapidly, with MRI and emerging biomarkers playing a central role in diagnosis, prognosis and disease monitoring. In this episode of the ECTRIMS Podcast, neurologist G
How much do the labels used to describe multiple sclerosis actually reflect the lived experience of people affected by the disease? In this first episode of the new ECTRIMS–MS Journal collaboration series, host Dr. Annek
Rehabilitation is more than exercise – it is a personalised process of learning and adaptation that empowers people living with MS to maximise independence, participation and quality of life. In this episode – recorded a
Clinical trial results unveiled today at ACTRIMS Forum 2026 suggest that fenebrutinib may be a novel and effective treatment option for people living with primary progressive multiple sclerosis. In this exclusive episode
What role does the gut microbiome play in multiple sclerosis — and how close are we to translating microbiome research into meaningful clinical interventions? In this episode of the ECTRIMS Podcast, host Brett Drummond i
Cognitive change is one of the most common—and most misunderstood—symptoms of multiple sclerosis. In this episode, host Brett Drummond speaks with Dr. Vicki Levitt (Columbia University) and Dr. Tom Fuchs (MS Center Amste
At every stage of the MS journey, nurses are the steady link between patients, families, and the healthcare team. In this episode, host Brett Drummond speaks with Amy Perrin Ross, MS Specialist Nurse and Program Coordina
While much of MS care focuses on physical symptoms, mental health challenges—like depression, anxiety, loneliness, and stigma—often go under-recognised. In this episode, host Brett Drummond speaks with Dr. Rebecca MaGuir
Patient Community Day 2025 set a new attendance record, highlighting the growing desire among people living with MS to connect with experts leading the charge in understanding the disease and advancing effective treatmen
At the late breaking abstracts session at ECTRIMS 2025 in Barcelona, the CCMR-Two trial revealed promising results for myelin repair in MS using the diabetes drug metformin and the antihistamine clemastine. Straight from
On the final day of ECTRIMS 2025 in Barcelona, the spotlight turned to MS treatment, including long-awaited clinical trial results. Dr. Sharmilee Gnanapavan, Consultant Neurologist at Barts Health and Princess Alexandra
Dr. Barry Singer, Director and Founder of The MS Center for Innovations in Care, joins host Brett Drummond to discuss the key takeaways unveiled on the second day of ECTRIMS 2025 in Barcelona.
Dr. Jiwon Oh
Medical Director of the Barlo Multiple Sclerosis Program at St. Michael’s Hospital · University of Toronto
2 appearances on this show
Kathryn Smith
Managing Director of Marketing · Black Lady Business School
1 appearance on this show
Amit Bar-Or
MD, FRCPC, FAAN, FANA · University of Pennsylvania
1 appearance on this show
Amit Bar-Or
MD, FRCPC, FAAN, FANA · University of Pennsylvania
1 appearance on this show
Prof. Letizia Leocani
Vita-Salute San Raffaele University
1 appearance on this show
Prof. Ellen Mowry
Johns Hopkins University
1 appearance on this show
Prof. Ludwig Kappos
University of Basel
1 appearance on this show
Dr. Blanca de Dios Pérez
University of Nottingham
1 appearance on this show
Prof. Roshan das Nair
SINTEF
1 appearance on this show
Stephen Hauser
University of California San Francisco
1 appearance on this show
Ashutosh Mangalam
University of Iowa
1 appearance on this show
Mahesh Desai
Luxembourg Institute of Health
1 appearance on this show
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
The ECTRIMS Podcast has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
The ECTRIMS Podcast is hosted by Unknown Host. The show is categorised under science (health) and has published 81 episodes.
The ECTRIMS Podcast has published 81 episodes.
The ECTRIMS Podcast regularly covers science, health, fitness. It sits in the science category, with a health focus.
The ECTRIMS Podcast is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
The ECTRIMS Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of The ECTRIMS Podcast average 27 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates The ECTRIMS Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.